Our New Alpha-Gal Syndrome Research Centers the Patient Experience

Our new peer-reviewed research on alpha-gal syndrome (AGS) begins with the patient experience.

In “Alpha-Gal Syndrome Is More than Meats the IgE: A Patient Survey of Symptoms, Diagnosis, and Burdens,” published today in the journal Healthcare, we looked at the experiences of more than 3,400 people with AGS to better understand what patients react to, what symptoms they experience, how long diagnosis can take, and what daily management looks like.

Key findings include:

• Patients reported a broader range of reactions than the common description of AGS as a “red meat allergy.” Reactions were linked to a variety of mammalian products, including meat, dairy, gelatin, medications, and personal-care products.
• The survey confirmed many known AGS symptoms: gastrointestinal, skin, respiratory, and cardiovascular. It also highlighted less-recognized symptoms, including emotional (e.g., anxiety), motor (e.g., tremors, stiffness), and nervous system symptoms (e.g., sweating), helping to build a fuller picture of how AGS can affect patients.
• Reaction timing was variable. While most reactions occurred four to eight hours after exposure, consistent with delayed reactions observed in AGS, patients also reported a wider window overall – from immediate reactions to symptoms beginning more than eight hours later.
• The study highlighted an important nuance about alpha-gal specific IgE testing. Among participants who reported their test results, a small number described negative results. This may reflect testing during a period when levels were below the cutoff or a declines over time, especially if patients avoided further tick bites. It reminds us that a test result is only one piece of the puzzle and must be considered alongside a patient’s history and symptoms.
• Time to diagnosis has improved but remains lengthy. Participants reported an average of about four years to obtain a diagnosis, compared with a previously reported average of seven years. While progress is encouraging, four years is still too long for people living with unexplained reactions.

For healthcare professionals, this research provides a fuller picture of what patients experience and highlights important questions that still need answers. We need further research to understand which products provoke reactions, how and why symptoms vary among individuals, and how clinicians can best counsel patients on management.

At TBC United, we believe patient experience should help shape the research, education, and care that follow a diagnosis. If you are an AGS patient and have not previously taken the survey, please visit this link.

View the full paper at Alpha-Gal Syndrome Is More than Meats the IgE: A Patient Survey of Symptoms, Diagnosis, and Burdens.